Erik Lipšic

4.7k total citations
103 papers, 2.9k citations indexed

About

Erik Lipšic is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Hematology. According to data from OpenAlex, Erik Lipšic has authored 103 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Cardiology and Cardiovascular Medicine, 23 papers in Radiology, Nuclear Medicine and Imaging and 23 papers in Hematology. Recurrent topics in Erik Lipšic's work include Cardiovascular Function and Risk Factors (25 papers), Acute Myocardial Infarction Research (24 papers) and Cardiac Imaging and Diagnostics (23 papers). Erik Lipšic is often cited by papers focused on Cardiovascular Function and Risk Factors (25 papers), Acute Myocardial Infarction Research (24 papers) and Cardiac Imaging and Diagnostics (23 papers). Erik Lipšic collaborates with scholars based in Netherlands, United States and United Kingdom. Erik Lipšic's co-authors include Dirk J. van Veldhuisen, Peter van der Meer, Wiek H. van Gilst, Pim van der Harst, Adriaan A. Voors, Regien G. Schoemaker, B. Daan Westenbrink, Hans L. Hillege, Robert H. Henning and Jan van Wijngaarden and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Erik Lipšic

89 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik Lipšic Netherlands	24	1.1k	1.1k	589	440	410	103	2.9k
B. Daan Westenbrink Netherlands	31	653 0.6×	2.0k 1.8×	899 1.5×	559 1.3×	263 0.6×	101	3.8k
Jonathan D. Marmur United States	35	649 0.6×	2.0k 1.9×	644 1.1×	1.8k 4.0×	423 1.0×	148	4.4k
Karen Douglas United Kingdom	30	505 0.5×	495 0.5×	317 0.5×	215 0.5×	203 0.5×	69	2.7k
Håkan Wallén Sweden	33	630 0.6×	1.0k 1.0×	945 1.6×	399 0.9×	245 0.6×	130	3.7k
Doyeun Oh South Korea	28	389 0.3×	506 0.5×	624 1.1×	309 0.7×	145 0.4×	103	2.2k
Patrick H Dessein South Africa	26	295 0.3×	544 0.5×	356 0.6×	276 0.6×	141 0.3×	86	2.7k
Lija Joseph United States	25	313 0.3×	613 0.6×	890 1.5×	392 0.9×	235 0.6×	44	2.5k
Hirofumi Soejima Japan	35	435 0.4×	2.0k 1.8×	652 1.1×	948 2.2×	171 0.4×	126	3.9k
Jean‐Noël Fiessinger France	32	822 0.7×	1.1k 1.0×	300 0.5×	960 2.2×	140 0.3×	80	3.0k
Martin Ellis Israel	28	718 0.6×	279 0.3×	304 0.5×	407 0.9×	174 0.4×	141	2.4k

Countries citing papers authored by Erik Lipšic

Since Specialization

Citations

This map shows the geographic impact of Erik Lipšic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Lipšic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Lipšic more than expected).

Fields of papers citing papers by Erik Lipšic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Lipšic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Lipšic. The network helps show where Erik Lipšic may publish in the future.

Co-authorship network of co-authors of Erik Lipšic

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Lipšic. A scholar is included among the top collaborators of Erik Lipšic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Lipšic. Erik Lipšic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Emmens, Johanna E., Jasper Tromp, Marcelle D. Smit, et al.. (2025). Association Between Antecedent Myocardial Infarction and Heart Failure with Preserved Versus Reduced Ejection Fraction. European Journal of Heart Failure. 27(12). 2918–2920.

Bogerd, Margriet, Jeroen J. H. Bunge, Marijke Timmermans, et al.. (2025). Clinical use and impact of mechanical circulatory support for myocardial infarction-related cardiogenic shock in the Netherlands: a registry-based propensity-matched analysis. Open Heart. 12(1). e002846–e002846.

Groot, Hilde E., et al.. (2024). Incidence and Predictors of Heart Failure with Reduced and Preserved Ejection Fraction After ST-Elevation Myocardial Infarction in the Contemporary Era of Early Percutaneous Coronary Intervention. European Journal of Heart Failure. 26(5). 1142–1149. 6 indexed citations

Mencke, Rik, Andreas Pasch, Magdalena Minnion, et al.. (2024). Serum Calcification Propensity Is Increased in Myocardial Infarction and Hints at a Pathophysiological Role Independent of Classical Cardiovascular Risk Factors. Arteriosclerosis Thrombosis and Vascular Biology. 44(8). 1884–1894. 5 indexed citations

Meijers, Wouter C., Iris E. Beldhuis, Hilde E. Groot, et al.. (2024). Association of fibrotic markers with diastolic function after STEMI. Scientific Reports. 14(1). 19122–19122. 2 indexed citations

Groot, Hilde E., Solmaz Assa, Erik Lipšic, et al.. (2023). Predictors of adverse diastolic remodeling in non-diabetic patients presenting with ST-elevation myocardial infarction. BMC Cardiovascular Disorders. 23(1). 44–44. 3 indexed citations

Collij, Valerie, Hilde E. Groot, Johannes R. Björk, et al.. (2023). The gut microbiome across the cardiovascular risk spectrum. European Journal of Preventive Cardiology. 31(8). 935–944. 15 indexed citations

Lipšic, Erik, Margery A. Connelly, Erwin Garcia, et al.. (2021). Temporal Course of Plasma Trimethylamine N-Oxide (TMAO) Levels in ST-Elevation Myocardial Infarction. Journal of Clinical Medicine. 10(23). 5677–5677. 10 indexed citations

Bor, Willem L., Saman Rasoul, E. Kaplan, et al.. (2021). Feasibility and safety of cangrelor in patients with suboptimal P2Y12 inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor Registry. BMC Cardiovascular Disorders. 21(1). 292–292. 2 indexed citations

10.

Assa, Solmaz, Dirk J. van Veldhuisen, Andreas Pasch, et al.. (2020). Safety and Tolerability of Sodium Thiosulfate in Patients with an Acute Coronary Syndrome Undergoing Coronary Angiography: A Dose-Escalation Safety Pilot Study (SAFE-ACS). Journal of Interventional Cardiology. 2020. 1–8. 21 indexed citations

11.

Hendriks, Tom, Joost P. van Melle, Yoran M. Hummel, et al.. (2019). Agreement of 2D transthoracic echocardiography with cardiovascular magnetic resonance imaging after ST-elevation myocardial infarction. European Journal of Radiology. 114. 6–13. 4 indexed citations

12.

Vlaar, Pieter J., Jan J.J. Aalberts, Niek H. J. Prakken, & Erik Lipšic. (2019). Left coronary artery anomaly: a case report of a hypoplastic and anomalous origin from the left ventricular outflow tract. European Heart Journal - Case Reports. 3(2).

13.

Wieringa, Wouter G., Chris P. H. Lexis, Erik Lipšic, et al.. (2017). In vivo coronary lesion differentiation with computed tomography angiography and intravascular ultrasound as compared to optical coherence tomography. Journal of cardiovascular computed tomography. 11(2). 111–118. 4 indexed citations

14.

Gorter, Thomas M., Chris P. H. Lexis, Yoran M. Hummel, et al.. (2016). Right Ventricular Function After Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the Glycometabolic Intervention as Adjunct to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction III Trial). The American Journal of Cardiology. 118(3). 338–344. 23 indexed citations

15.

Lipšic, Erik, B. Daan Westenbrink, Peter van der Meer, et al.. (2008). Low-Dose Erythropoietin Improves Cardiac Function in Experimental Heart Failure without Increasing Haematocrit. European Journal of Heart Failure. 10(1). 22–29. 62 indexed citations

16.

Xu, Ying, Robert H. Henning, Erik Lipšic, et al.. (2006). Acetylcholine Stimulated Dilatation and Stretch Induced Myogenic Constriction in Mesenteric Artery of Rats with Chronic Heart Failure. European Journal of Heart Failure. 9(2). 144–151. 10 indexed citations

17.

Lipšic, Erik, et al.. (2006). Low-dose erythropoietin treatment preserves cardiac function and mobilizes endothelial progenitor cells in rats with ischemic heart failure. Data Archiving and Networked Services (DANS). 1 indexed citations

18.

Lipšic, Erik, et al.. (2005). Anaemia predicts cardiovascular events in patients with stable coronary artery disease.. PubMed Central. 13(7-8). 254–258. 6 indexed citations

19.

Meer, Peter van der, Erik Lipšic, Robert H. Henning, et al.. (2004). Erythropoietin Improves Left Ventricular Function and Coronary Flow in an Experimental Model of Ischemia-Reperfusion Injury. European Journal of Heart Failure. 6(7). 853–859. 79 indexed citations

20.

Meer, Peter van der, Adriaan A. Voors, Erik Lipšic, et al.. (2004). Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure. Journal of the American College of Cardiology. 44(1). 63–67. 157 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact